Drugs & Biotechnology | Page 2 | MarketPublishers.com

Business, Finance & Insurance
- Banking & Finance (1695)
- Insurance (724)
- Real Estate (316)
- Business Services (1486)
- Business Survey (357)
Consumer Goods & Retail
- Cosmetics (1586)
- Food & Beverage (13218)
- Textile (1512)
- TV & Entertainment (616)
- Other Consumer Goods (3154)
- Consumer Durables & Capital Goods (1056)
- Household & Personal Products (3108)
- Retailing (6252)
Industry
- Chemicals & Petrochemicals (72030)
- Construction (8030)
- Energy (7675)
- Light Industry (1663)
- Machinery & Equipment (3976)
- Metallurgy (1734)
- Raw Materials, Fillers (1555)
- Transportation (1422)
- Agriculture (3218)
- Other Industries (3625)
Medicine, Pharmaceuticals & Biotechnology
- Drugs & Biotechnology (7692)
- Healthcare Equipment & Services (11243)
Services
- Restaurants (666)
- Transport & Logistics (1183)
- Travel & Leisure (617)
- Hotels (100)
- Business services & supplies (222)
- Other Services (977)
Technologies & Electronics
- Computers (464)
- Electronic Devices (2964)
- Media (648)
- Telecommunications (3914)
- Software & Services (720)
- Semiconductors (240)
- Hardware & Equipment (449)
Social Researches
- Demographics (33)
- Social Studies (156)
- Government (235)
Education & Consulting
Databases & Statistics
Company Reports
Reports by Region

About Us Market Reports FAQ Login/Register

+44 20 8123 2220
+1 732 587 5005
info@marketpublishers.com

Market Research Reports > Medicine, Pharmaceuticals & Biotechnology > Drugs & Biotechnology

Found 7694 publications

Telavancin - Comprehensive patent search Jan, 2012	US$ 7,200.00
Retigabine - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Retigabine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Retigabine - Comprehensive patent search Jan, 2012	US$ 6,400.00
Liraglutide - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Liraglutide - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Fidaxomicin - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Fidaxomicin - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Fidaxomicin - Comprehensive patent search Jan, 2012	US$ 7,200.00
Eslicarbazepine - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Eslicarbazepine - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Eslicarbazepine - Comprehensive patent search Jan, 2012	US$ 6,400.00
Ceftaroline Fosamil - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Ceftaroline Fosamil - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Ceftaroline Fosamil - Comprehensive patent search Jan, 2012	US$ 7,200.00
Cefixime - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Cefixime - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00
Cefixime - Comprehensive patent search Jan, 2012	US$ 7,200.00
Ambrisentan - Key patent, SPC, and data exclusivity expiry (7 country coverage) Jan, 2012	US$ 500.00
Ambrisentan - Key patent, SPC, and data exclusivity expiry (44 country coverage) Jan, 2012	US$ 1,200.00

1 2 3 4 5 6 7 8 9 10 11 ... 385

Home FAQ Terms & Conditions Contact Us